MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pgr2.70036

Медицинская библиотека · Proteoglycan research · 2025

Hyaluronidases as Targets for the Treatment of Neurological Diseases.

Sherman Larry S, Sorg Barbara A, Matsumoto Steven, Su Weiping, Banine Fatima, Back Stephen A

СтатьяПеревод в очереди

Аннотация

Hyaluronan (HA) is a glycosaminoglycan synthesized at the cell membrane that can exist in numerous states in the extracellular matrix, including in ternary complexes with proteoglycans such as aggrecan and neurocan. HA synthesis is elevated following a wide variety of insults to the central nervous system (CNS) including neuroinflammatory disease, ischemia, and various forms of dementia. Recent studies have demonstrated that, in conjunction with increased HA synthesis, the expression and activities of hyaluronidases that digest HA are also elevated in the injured CNS. While high molecular weight forms of HA have their own functions that can be disrupted by hyaluronidases, digestion products of HA generated by these hyaluronidases have their own, distinct biological activities that can impact recovery from CNS damage. Here, we review some of the conditions and diseases in which hyaluronidase activity can play a role in preventing CNS repair and discuss the potential ways that hyaluronidase inhibitors could be used as therapeutic agents.

Для цитирования: Sherman Larry S, Sorg Barbara A, Matsumoto Steven, Su Weiping, Banine Fatima, Back Stephen A. Hyaluronidases as Targets for the Treatment of Neurological Diseases.. Proteoglycan research. 2025. DOI: 10.1002/pgr2.70036.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.